Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chondrocytes | 13 | 2020 | 136 | 2.040 |
Why?
|
| SOX9 Transcription Factor | 7 | 2016 | 9 | 1.750 |
Why?
|
| Nucleus Pulposus | 2 | 2016 | 7 | 1.070 |
Why?
|
| Protein Kinase C | 13 | 2003 | 45 | 0.810 |
Why?
|
| Mitogen-Activated Protein Kinases | 13 | 2003 | 28 | 0.810 |
Why?
|
| Gene Expression Regulation | 4 | 2020 | 232 | 0.700 |
Why?
|
| Annulus Fibrosus | 2 | 2017 | 5 | 0.670 |
Why?
|
| Animals | 26 | 2023 | 3377 | 0.640 |
Why?
|
| Cells, Cultured | 15 | 2020 | 467 | 0.600 |
Why?
|
| Cell Differentiation | 8 | 2016 | 111 | 0.590 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2014 | 63 | 0.560 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2016 | 1 | 0.550 |
Why?
|
| Signal Transduction | 13 | 2020 | 380 | 0.550 |
Why?
|
| Growth Plate | 1 | 2016 | 15 | 0.540 |
Why?
|
| Pyridines | 2 | 2016 | 36 | 0.540 |
Why?
|
| rho-Associated Kinases | 1 | 2016 | 5 | 0.530 |
Why?
|
| Collagen Type II | 4 | 2016 | 15 | 0.530 |
Why?
|
| Amides | 1 | 2016 | 15 | 0.530 |
Why?
|
| Chondrogenesis | 5 | 2003 | 29 | 0.480 |
Why?
|
| Isoenzymes | 8 | 2002 | 45 | 0.440 |
Why?
|
| Mesoderm | 8 | 2003 | 19 | 0.430 |
Why?
|
| Cartilage, Articular | 5 | 2020 | 374 | 0.390 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 6 | 2000 | 18 | 0.380 |
Why?
|
| Apoptosis | 5 | 2003 | 187 | 0.370 |
Why?
|
| Genome | 1 | 2010 | 8 | 0.350 |
Why?
|
| Rats | 4 | 2016 | 598 | 0.350 |
Why?
|
| Mice, Knockout | 5 | 2020 | 233 | 0.340 |
Why?
|
| Binding Sites | 3 | 2016 | 64 | 0.340 |
Why?
|
| Mice | 10 | 2023 | 1197 | 0.330 |
Why?
|
| Intervertebral Disc Degeneration | 2 | 2022 | 77 | 0.290 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 7 | 2003 | 16 | 0.290 |
Why?
|
| Cartilage | 6 | 2010 | 93 | 0.270 |
Why?
|
| Enzyme Inhibitors | 8 | 2016 | 121 | 0.270 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 11 | 2003 | 21 | 0.240 |
Why?
|
| Osteoarthritis | 2 | 2020 | 303 | 0.230 |
Why?
|
| Intervertebral Disc | 2 | 2016 | 89 | 0.230 |
Why?
|
| Nitric Oxide | 5 | 2003 | 84 | 0.230 |
Why?
|
| Endothelial Cells | 1 | 2023 | 57 | 0.220 |
Why?
|
| Musculoskeletal Diseases | 1 | 2023 | 40 | 0.210 |
Why?
|
| Bone Regeneration | 1 | 2023 | 68 | 0.210 |
Why?
|
| Enzyme Activation | 9 | 2003 | 97 | 0.210 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2003 | 52 | 0.210 |
Why?
|
| Chick Embryo | 8 | 2003 | 11 | 0.210 |
Why?
|
| Microbiota | 1 | 2023 | 95 | 0.210 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 8 | 2003 | 30 | 0.200 |
Why?
|
| Caspases | 5 | 2003 | 26 | 0.200 |
Why?
|
| Macrophages | 2 | 1999 | 104 | 0.200 |
Why?
|
| Awards and Prizes | 1 | 2022 | 19 | 0.200 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 125 | 0.200 |
Why?
|
| Sirolimus | 1 | 2001 | 15 | 0.190 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 179 | 0.190 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2022 | 73 | 0.180 |
Why?
|
| Malocclusion | 1 | 2020 | 1 | 0.180 |
Why?
|
| Osteogenesis | 2 | 2023 | 96 | 0.180 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2020 | 7 | 0.180 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 119 | 0.180 |
Why?
|
| Low Back Pain | 1 | 2022 | 111 | 0.180 |
Why?
|
| Receptors, Vitronectin | 1 | 2000 | 5 | 0.180 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 11 | 0.170 |
Why?
|
| Metformin | 1 | 2020 | 18 | 0.170 |
Why?
|
| Receptors, Laminin | 1 | 1999 | 1 | 0.170 |
Why?
|
| Up-Regulation | 1 | 2020 | 131 | 0.160 |
Why?
|
| Menisci, Tibial | 2 | 2020 | 155 | 0.160 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2016 | 9 | 0.160 |
Why?
|
| Cell Proliferation | 2 | 2016 | 145 | 0.160 |
Why?
|
| Base Sequence | 2 | 2016 | 86 | 0.150 |
Why?
|
| Gene Expression | 2 | 2017 | 176 | 0.150 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2017 | 35 | 0.140 |
Why?
|
| Receptors, CCR5 | 1 | 2017 | 13 | 0.140 |
Why?
|
| Introns | 1 | 2016 | 14 | 0.140 |
Why?
|
| Sternum | 1 | 2016 | 4 | 0.140 |
Why?
|
| Cell Movement | 1 | 2017 | 72 | 0.140 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2016 | 9 | 0.140 |
Why?
|
| Gene Deletion | 1 | 2016 | 32 | 0.140 |
Why?
|
| Extremities | 1 | 2016 | 28 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 63 | 0.130 |
Why?
|
| Osteoblasts | 1 | 2016 | 50 | 0.130 |
Why?
|
| Cell Line, Transformed | 1 | 2016 | 14 | 0.130 |
Why?
|
| Interleukin-1 | 2 | 2014 | 39 | 0.130 |
Why?
|
| Protein Binding | 2 | 2014 | 108 | 0.130 |
Why?
|
| Bone and Bones | 2 | 2023 | 107 | 0.130 |
Why?
|
| RNA, Messenger | 1 | 2016 | 240 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 304 | 0.120 |
Why?
|
| Cadherins | 4 | 2003 | 35 | 0.120 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2014 | 1 | 0.120 |
Why?
|
| Nucleotide Motifs | 1 | 2014 | 2 | 0.120 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 15 | 0.120 |
Why?
|
| Protein Transport | 1 | 2014 | 31 | 0.120 |
Why?
|
| Humans | 10 | 2023 | 25178 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 41 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2014 | 38 | 0.120 |
Why?
|
| Trans-Activators | 3 | 2003 | 20 | 0.120 |
Why?
|
| Cell Line | 3 | 2010 | 240 | 0.120 |
Why?
|
| Blotting, Western | 3 | 2003 | 128 | 0.110 |
Why?
|
| Down-Regulation | 4 | 2016 | 90 | 0.110 |
Why?
|
| Inflammation | 1 | 2014 | 253 | 0.100 |
Why?
|
| Cell Division | 3 | 2001 | 71 | 0.100 |
Why?
|
| Caspase 3 | 5 | 2003 | 19 | 0.100 |
Why?
|
| Fibronectins | 3 | 2000 | 20 | 0.100 |
Why?
|
| Cell Adhesion | 3 | 2000 | 29 | 0.100 |
Why?
|
| Protein Kinase C-alpha | 5 | 2002 | 6 | 0.100 |
Why?
|
| Limb Buds | 2 | 2009 | 2 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2003 | 307 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2010 | 5 | 0.090 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 23 | 0.090 |
Why?
|
| Rabbits | 4 | 2003 | 217 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 44 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 30 | 0.090 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2000 | 26 | 0.090 |
Why?
|
| Integrins | 2 | 2000 | 12 | 0.090 |
Why?
|
| Body Patterning | 1 | 2009 | 2 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 62 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 3 | 2003 | 18 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 512 | 0.070 |
Why?
|
| Phosphorylation | 3 | 2001 | 135 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 300 | 0.070 |
Why?
|
| Collagen | 3 | 2003 | 65 | 0.070 |
Why?
|
| Matrix Metalloproteinase 13 | 2 | 2017 | 24 | 0.070 |
Why?
|
| Disease Progression | 2 | 2020 | 649 | 0.070 |
Why?
|
| Flavonoids | 5 | 2003 | 15 | 0.060 |
Why?
|
| Tretinoin | 1 | 2003 | 14 | 0.060 |
Why?
|
| Protein Kinases | 1 | 2003 | 13 | 0.060 |
Why?
|
| Bacteria | 1 | 2023 | 70 | 0.050 |
Why?
|
| Oxygen | 1 | 2023 | 73 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 43 | 0.050 |
Why?
|
| Gastrointestinal Tract | 1 | 2023 | 50 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 183 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2023 | 73 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 2 | 2000 | 16 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2003 | 91 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1999 | 30 | 0.050 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2001 | 1 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2001 | 26 | 0.050 |
Why?
|
| Carbazoles | 1 | 2000 | 6 | 0.050 |
Why?
|
| Facial Pain | 1 | 2020 | 5 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2001 | 80 | 0.050 |
Why?
|
| Temporomandibular Joint | 1 | 2020 | 9 | 0.050 |
Why?
|
| Nociception | 1 | 2020 | 10 | 0.050 |
Why?
|
| Sulfonamides | 1 | 2000 | 39 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2020 | 5 | 0.040 |
Why?
|
| Cell Fractionation | 1 | 2000 | 5 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2000 | 27 | 0.040 |
Why?
|
| Random Allocation | 1 | 2020 | 106 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 30 | 0.040 |
Why?
|
| Integrin alpha6beta1 | 1 | 1999 | 1 | 0.040 |
Why?
|
| Protein Kinase C-delta | 1 | 1999 | 7 | 0.040 |
Why?
|
| Laminin | 1 | 1999 | 8 | 0.040 |
Why?
|
| Proteoglycans | 2 | 2014 | 124 | 0.040 |
Why?
|
| Time Factors | 2 | 2001 | 1327 | 0.040 |
Why?
|
| Receptors, Muscarinic | 1 | 1999 | 5 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 467 | 0.040 |
Why?
|
| Child | 1 | 2022 | 1232 | 0.040 |
Why?
|
| beta Catenin | 3 | 2003 | 47 | 0.040 |
Why?
|
| Nitroprusside | 3 | 2002 | 6 | 0.040 |
Why?
|
| Aggrecans | 1 | 2017 | 61 | 0.040 |
Why?
|
| SOXD Transcription Factors | 1 | 2016 | 1 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2017 | 77 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 1113 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 2022 | 388 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 86 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2009 | 29 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 232 | 0.030 |
Why?
|
| Risk Factors | 1 | 2022 | 2166 | 0.030 |
Why?
|
| Cytokines | 1 | 2017 | 200 | 0.030 |
Why?
|
| ADAMTS5 Protein | 1 | 2014 | 23 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2014 | 33 | 0.030 |
Why?
|
| Transfection | 1 | 2014 | 98 | 0.030 |
Why?
|
| Homeostasis | 1 | 2014 | 51 | 0.030 |
Why?
|
| Cattle | 1 | 2014 | 145 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2014 | 169 | 0.030 |
Why?
|
| ADAM Proteins | 1 | 2014 | 46 | 0.030 |
Why?
|
| alpha Catenin | 2 | 2003 | 2 | 0.030 |
Why?
|
| Nitric Oxide Donors | 2 | 2002 | 7 | 0.030 |
Why?
|
| Phenotype | 2 | 2002 | 283 | 0.020 |
Why?
|
| Caspase Inhibitors | 2 | 2001 | 4 | 0.020 |
Why?
|
| Dimerization | 1 | 2010 | 13 | 0.020 |
Why?
|
| Chromatin | 1 | 2010 | 13 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 53 | 0.020 |
Why?
|
| DNA | 1 | 2010 | 89 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 186 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 1999 | 11 | 0.020 |
Why?
|
| Mutation | 1 | 2010 | 306 | 0.020 |
Why?
|
| Male | 1 | 2022 | 13545 | 0.020 |
Why?
|
| Female | 1 | 2022 | 13844 | 0.020 |
Why?
|
| Cytochalasin D | 1 | 2003 | 5 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2002 | 10 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 20 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2002 | 8 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 45 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 136 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2001 | 18 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2001 | 27 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2001 | 99 | 0.010 |
Why?
|
| Imidazoles | 1 | 2001 | 59 | 0.010 |
Why?
|
| Embryonic Induction | 1 | 2000 | 1 | 0.010 |
Why?
|
| Receptors, Fibronectin | 1 | 2000 | 1 | 0.010 |
Why?
|
| Isoquinolines | 1 | 2000 | 12 | 0.010 |
Why?
|
| Pyrroles | 1 | 2000 | 23 | 0.010 |
Why?
|
| Indoles | 1 | 2000 | 36 | 0.010 |
Why?
|
| Models, Biological | 1 | 2001 | 299 | 0.010 |
Why?
|
| Bucladesine | 1 | 1999 | 2 | 0.010 |
Why?
|
| Mitogens | 1 | 1999 | 5 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 1999 | 13 | 0.010 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 1999 | 1 | 0.010 |
Why?
|
| Carbachol | 1 | 1999 | 4 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1999 | 6 | 0.010 |
Why?
|
| Protein Kinase C-epsilon | 1 | 1999 | 2 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1999 | 16 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1999 | 117 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1998 | 18 | 0.010 |
Why?
|